SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is currently trending, driven by community discussions around its rumored major collaboration with POL and a recent integration with ACH, which is viewed as a meaningful expansion of its utility. Many investors are actively anticipating this "OG privacy coin" to follow the strong upward momentum observed in Zcash, amidst a broader resurgence of interest in privacy tokens.

"What's Updog?" is a Community Led token.

UpDog

UpDog Crypto is trending primarily due to its community's playful engagement around the classic 'What's UpDog?' meme, serving as a viral talking point across social platforms. Enthusiasts are actively promoting this Solana-based token, highlighting its established presence and encouraging new participants to 'load UpDog' as a community-driven initiative. The coin often appears in posts congratulating other symbols for 'trending UpDog,' solidifying its role as a lighthearted indicator within the crypto conversation.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its highly engaged community champions the "OG meme" narrative of Rage Comics, positioning it as a "foundational meme reset" for the current market cycle. This dedicated base actively builds an ecosystem with platforms like RageMaker and RageGames, expressing strong conviction and urging fellow enthusiasts to "Return to the Memes" and "Rage On" to reclaim leadership in the meme coin space.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is currently trending with its community enthusiastically discussing strategic partnerships, notably with World Liberty Finance, and potential collaborations with major blockchain ecosystems like Stellar and Ripple. The overwhelmingly bullish sentiment centers on ZBCN's real-world utility in on-chain payroll and strong regulatory compliance, with many anticipating significant growth as the Super App launch approaches and final token unlocks occur.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is drawing significant attention following its recent acquisition of VLX-1005, expanding its pipeline, alongside an active capital raise. While bullish investors are eyeing the low float and potential for significant upside driven by its clinical progress and ambitious price targets, a vocal segment of the community remains highly skeptical, frequently discussing ongoing dilution, cash burn, and widespread "scamming bot" activity. This biotech is at the center of a heated debate between those seeing transformative potential and those concerned about its financial viability and market manipulation.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy (MULN CRYPTO) is actively trending amid widespread community skepticism, largely fueled by its association with Mullen Automotive's stock history. Many users are calling the token a "scam" or "rug pull," drawing parallels to past investor losses and significant dilution experienced with the original equity. This intense discussion is set against the backdrop of an ongoing settlement for former Mullen Automotive stock investors, further highlighting the contentious legacy linked to the "Mullen" name.

The ticket is $Testicle. EVERY SINGLE ONE OF YOU CAME FROM A $Testicle. $Testicle always bounce.   We have a website on which you can create art or memes. We have a community. We have a raid group. We aim to provide the best testicular care on CT.   We might even have to call on our nefarious leader, Harry Bolz. Alright Chad, SACK TF. Or else you’re a Low T beta male.   If you have questions and or concerns please feel to reach out to a team member on how you can acquire or become a high testosterone male in a sea of betas. I mean how else does one live if not as a High T male?

Testicle

TESTICLE CRYPTO is trending due to its provocative name and status as a new meme coin, drawing significant, often humorous, attention from the crypto community. Many are discussing it with a mix of ironic 'all-in' statements and comparisons to other similarly themed tokens like $BALLSACK, while others express disbelief and question the overall direction of the altcoin market. This token embodies the ongoing debate and fascination with the rapidly evolving and often outlandish meme cryptocurrency sector.

Kaspa was fair-launched in November 2021 with no pre-mine, zero pre-sale, and no coin allocations, and is 100 percent community-managed. Kaspa aims to be the world's global sequencer for traditional finance and decentralized crypto markets by utilizing proof-of-work and its BlockDAG consensus protocol, GHOSTDAG. Being the world's fastest proof-of-work network, Kaspa combines five properties: (1) hard money principles, (2) Bitcoin's ethos of security-first fundamentals (boasting a security threshold of fifty percent with significant market hashrate), (3) decentralization from rapid block rate mining, (4) block speeds faster than any PoW or PoS network, and (5) smart contract development through based-rollups without fragmented liquidity. Ushering in all five properties, Kaspa is on track to fulfill Satoshi Nakamoto's vision of a digital medium of exchange while also advancing global layer-one sequencing and minuscule confirmation times dominated by internet latency (cf. chapter 6 of the the paper for some initial benchmarks). The Kaspa implementation includes a lot of cool features and subprotocols including Reachability to query the DAG's topology, Block data pruning (with near-future plans for block header pruning), SPV proofs, and later subnetwork support which will make future implementation of layer 2 solutions much easier.

Kaspa

KAS CRYPTO is currently a hot topic as the community anticipates imminent smart contract capabilities and stablecoin integration, aiming to boost its utility. Enthusiasts highlight its innovative BlockDAG technology, fair launch, and potential as a scalable Proof-of-Work network, while others express frustration over its market performance and the continued absence of Tier-1 exchange listings.

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Arbitrum is currently trending due to significant institutional adoption, with Robinhood integrating its platform for tokenized stocks and PayPal utilizing it for stablecoin support. The community widely views ARB as a leading Ethereum Layer 2, emphasizing its robust stablecoin market and substantial net inflows as key drivers for its perceived long-term value in the real-world asset tokenization sector. Despite discussions around token unlocks, many anticipate its continued growth given its critical role in scaling the Ethereum ecosystem.

Founded in 2018, Concordium is the Layer-1 blockchain built for a new era of digital trust.  Our name comes from the Latin concordia—meaning harmony and agreement—a reflection of our mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.  At the heart of Concordium is Smart Money: programmable digital assets with identity, policy controls, and compliance embedded at the protocol level. Smart Money enables frictionless digital interactions with security, automation, and regulatory certainty by design.  Concordium was established by Lars Seier Christensen, founder of Saxo Bank, inspired by the recognition that blockchain’s full potential can only be realized if it works with regulation, not against it. That insight led to a new model of trust—one where decentralization and accountability can coexist.  Backed by world-class cryptographic research and a global team with expertise across  blockchain, finance, and compliance, Concordium delivers protocol-native features like zero- knowledge verification, programmable compliance, and privacy-preserving controls—  empowering a smarter, more connected financial future.

Concordium

Concordium (CCD) is trending as its compliance-first Layer-1 blockchain, featuring protocol-level identity and zero-knowledge proofs, captures significant attention for PayFi and stablecoin infrastructure. The community is actively discussing its unique position in bridging traditional finance with Web3 through regulatory readiness and privacy with accountability. This focus on verifiable trust and enterprise-grade utility, alongside recent strategic investments and partnerships, positions CCD as a foundational technology for a regulated digital economy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SENS Stock Up as Eversense 365 Enters AID Market With twiist System

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.

<ul class="summary-bullets"><li>Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.&nbsp;</li><li>Combining twiist with Senseonics’s Eversense 365 marks the first time when a one-year CGM system has been integrated with an AID, the company said.</li><li>The commercial launch of the integrated products provides people with type 1 diabetes a new level of flexibility and personalization in their diabetes management.</li></ul>Shares of Senseonics Holdings, Inc. (SENS) closed over 8% higher on Thursday after the company announced the first commercial usage of its year-long implantable Eversense 365 Continuous Glucose Monitor (CGM) with Sequel MedTech’s Automated Insulin Delivery (AID) system.Senseonics said that alongside Sequel, it has launched the integration of the products with the first patients having received a Sequel twiist AID system paired with the Eversense 365 CGM.Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.The company’s shares were up 0.14% in after-market hours at the time of writing.<h2 class="st-heading-2">World’s First AID Integration</h2>Combining twiist with Senseonics’s Eversense 365 marks the first time when a one-year CGM system has been integrated with an AID, representing a major milestone in long-term diabetes management by reducing the need for regular sensor changes and re-pairing, while maintaining exceptional accuracy, the company said.“Patients and providers want reliable, long-term automated glucose readings and we’ve taken a major step forward in simplifying and personalizing diabetes management by integrating Eversense 365’s One Year CGM system with the twiist AID system for patients that require insulin,” Goodnow said.Meanwhile, Alan Lotvin, CEO of Sequel MedTech said that diabetes management is deeply personal, and no single approach works for everyone. “Our focus on personalization means Sequel is committed to creating choice for people living with diabetes; integration with the Eversense CGM is an important step in this journey, enabling more people to experience the precision and confidence that twiist AID system brings to diabetes management,” he added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around SENS stock stayed in the ‘bullish’ territory over the past day amid ‘high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_09_at_3_22_54_AM_png_4f2919b8d5.webp" alt="On Stocktwits, retail sentiment around SENS stock stayed in the ‘bullish’ territory over the past day amid ‘high’ message volumes." width="1303" height="157"></figure><a href="https://stocktwits.com/symbol/SENS">Shares of SENS</a> have lost over 17% of their value in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

An Asian teenager with type 1 diabetes uses an at home glucometer to test his blood sugar levels. | Image source: Getty Images

SENS Shares Surge After First Commercial Patients Use AID-Integrated Continuous Glucose Monitor System

Senseonics announced the first commercial usage of its year-long implantable Eversense 365 Continuous Glucose Monitor (CGM) with Sequel MedTech’s Automated Insulin Delivery (AID) system.

Equity

Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Rating of "Buy" from Analysts

Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) has been given an average recommendation of "Buy" by the six analysts that are covering the company, MarketBeat.com reports. One equities...

Maven Securities LTD Takes Position in Senseonics Holdings, Inc. $SENS

Maven Securities LTD acquired a new stake in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and...

Hood River Capital Management LLC Invests $3.78 Million in Senseonics Holdings, Inc. $SENS

Hood River Capital Management LLC acquired a new position in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the second quarter, according to the company in its most recent...

Vistagen Appoints Nick Tressler as Chief Financial Officer

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product...

Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of -30.30% and +1.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Clover Health Investments, Corp. (CLOV) Reports Break-Even Earnings for Q3

Clover Health Investments (CLOV) delivered earnings and revenue surprises of -100.00% and +4.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Doximity (DOCS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Doximity (DOCS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Current Price	$7.80
Prev Close	$7.27
Open	$7.28
Dividend Yield	0.00%
50-Day Moving Average	$6.35
Beta	1.75
Avg. Volume	432,142.86
PE Ratio	-4.54

52-Week High	$28.00
52-Week Low	$5.25
Market Capitalization	$317.06M
EPS (Annual)	-$2.50
Price to Book	4.05
Revenue Per Employee	$192,068.38
Enterprise Value/EBITDA	N/A

SENS
Senseonics Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SENS News

SENSSenseonics Holdings Inc